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Abstract 
Technology has important effects on business operations in the medical field, and 
innovation plays a crucial role in sustaining health. One of these innovations is telemedicine, 
which broadly refers to the use of telecommunications technologies in medical delivery of care. 
This service allows for the remote diagnosis and management of patient’s health, and has 
recently been employed to improve patient outcomes across a large scope of medical problems. 
The purpose of this research is to look into the success of telemedicine interventions in the 
prevention and treatment of cardiovascular disease management in patients, and to analyze 
whether these interventions bring better results than the normal care routine. As cardiovascular 
disease and other heart problems affect the health of many people around the world, telemedicine 
interventions can be used to provide health care to those with CVD, and to help monitor those at 
high risk for heart disease (prevention of CVD). For this reason, this research focuses solely on 
the use of telemedicine in patients with cardiovascular conditions. The hypothesis is that 
telemedicine interventions used in the included cardiovascular condition management scenarios 
are beneficial, and have a positive relationship with health outcomes for patients.  Though 
previous studies have been conducted to test these telemedicine interventions in CVD, they have 
shown conflicting results. This project provides a systematic review and meta-analysis that 
statistically combines data from multiple studies. A search of several databases has provided 
relevant controlled studies that fulfilled the criteria for inclusion in this review. The selected 
studies were analyzed using quality outcome measures including hospitalizations and mortality 
rates. Overall the trends in relative risk showed a lower risk of mortality and hospitalizations 
with telemedicine when compared to usual care, yet the evidence is not strong enough to signify 
statistical significance. 
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Introduction 
Technology is an ample part of our society and the foundation upon which improvement 
and advancements are made. Thus, it is an integral factor to consider in all industries, including 
health care. Within health care, telemedicine has been employed as a technology application to 
improve patient outcomes across a large scope of medical problems. The research conducted 
here will focus on investigating the value of telemedicine within cardiovascular interventions. To 
measure the success of these interventions a systematic method of collecting a set of clinical 
interventions, which meet the requirements to be considered, will be used. Next the data taken 
from these studies will be combined to statistically evaluate. This research will use quality 
measures to quantifiably analyze patient outcomes. By combining studies this research will be 
able to gather a more collaborative view of the relative interventions, and increase the power of 
their results. The purpose of this research is to take a look at the results of telemedicine 
interventions in the prevention and treatment of cardiovascular disease management in patients. 
In summary this research aims to analyze through patient outcome measures, including mortality 
and all cause hospitalizations, whether these interventions bring better results than the normal 
care routine. 
Background 
Innovation and adaptation to achieve better health outcomes are driving changes in the 
delivery of healthcare. Since around the 1990’s, telemedicine, a technology based intervention, 
has radically increased in interest and utilization in health care. Telemedicine largely refers to the 
use of telecommunications technologies in medical delivery of care. This service allows for the 
remote diagnosis and treatment of patients, which can be beneficial in the obvious situation of 
when patients and their healthcare professional are not in the same location. (4) Since its 
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evolution, this tactic has taken hold in a variety of medical fields. Now that a large number of 
telemedicine interventions have taken place, it’s important to show the value of the results in 
ways such as an analysis of patient outcomes. One way to measure the success of these 
implementations is through patient outcomes. Quality measures can be used to help quantify 
health care processes effects.  
 Cardiovascular disease (CVD) has been a leading cause of death for many years now. It 
is a huge problem in health care and one that many have been striving to improve upon. There 
are many forms of heart disease including; hypertensive heart disease, rheumatic heart disease, 
coronary artery and heart disease, heart attacks, strokes, congenital heart disease, heart failure, 
high blood pressure, and arrhythmia. (9) With each of these conditions there are many different 
sets of treatments. As cardiovascular disease and other heart problems affect the health of many 
people around the world, telemedicine interventions can be used in the management of those 
with CVD, and to help monitor those at high risk for heart disease (prevention of CVD). This 
research will focus on the remote monitoring of patients with cardiovascular conditions. This 
type of care moves out of the clinical setting and into the patients home and makes it possible for 
clinicians to intervene before arriving at the hospital or medical site. The use of internet, 
telephone and videoconferencing is being closely supervised to transmit data about patients to 
healthcare professionals. The focus of this research project will be evaluating the innovative 
models present in randomized controlled trials and controlled clinical trials that include the 
transmission of physiologic parameters and symptoms from patients with cardiovascular 
conditions. These telemedicine interventions allow for the remote home monitoring of patients, 
even after being discharged, through electronic transmission of physiologic parameters and 
symptoms from patients to health professionals who monitor this information. It should be noted 
9 
 
that this is different than individual home monitoring, which will not be included in the selected 
cases. Personal home monitoring can be defined as telehealth innovations that are used solely by 
individuals to track their own health. For the purposes of this research, it will be required that 
telemedicine interventions transmit information to health care professionals.  
Literature Review 
This specific research project progressed from a wide variety of related research in this area, 
and will employ many of the existing methods. By combining methods in different studies this 
project will use the related research as a starting point and build upon it to provide a new 
perspective and analysis of the concept explained above.  
Young et.al. (23) addresses the effect of telemedicine coverage in the intensive care unit on 
patient outcomes. This relationship was shown through a systematic review and meta-analysis of 
13 studies, covering over 41,000 patients. This specific project plans to use a lot of the same 
methodology behind this systematic review and meta-analysis that is to be used in this research 
project. However, instead of searching for ICU telemedicine interventions, the Boolean search 
will be changed to look for cardiovascular interventions.  Reduced ICU mortality and LOS were 
shown, but not all cause mortality. These health outcome measures used in Young’s study can be 
analyzed in a comparable manner to those used in this research.  
García-Lizana and Sarría-Santamera (10) led a systematic review on the effectiveness of 
telemedicine interventions used to control chronic diseases. Online databases were searched and 
56 studies were chosen to be potentially included in this review of measured clinical indicators. 
The results showed no overall improvement in clinical outcomes, however no negative effects 
either. One interesting and relevant key finding from this article was that the intervention studies 
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looking at telemedicine used to follow up on cardiovascular disease showed better clinical 
outcomes (mortality reduction) than the rest of the studies. This is interesting in particular 
because it has a direct relation to the area of telemedicine that is being chosen to study further in 
this research project. The data from this work of García-Lizana and Sarría-Santamera (2007) has 
a role in the hypothesis of this research because it speaks to the effectiveness of telemedicine 
interventions in reducing mortality within the specialization this project will focus on, 
cardiovascular conditions.  
DelliFraine and Dansky (8) also use a review and meta-analysis to analyze home-based 
telehealth. This publication looked at the same type of home based remote tele monitoring that 
was the researched intervention type of our own study. However, they looked at these telehealth 
interventions for all medical reasons, where we are specifically researching patients with 
cardiovascular conditions. DelliFraine and Dansky did conduct a sub group analysis that relates 
explicitly related to our research. They reported results indicating a moderately positive 
relationship between telehealth and heart failure outcomes and that no studies found a significant 
negative outcome. This provides further basis for our hypothesis that telemedicine should 
improve health outcomes and the management, treatment, and prevention of cardiovascular 
conditions.  
The publication by Clark et.al. (5) includes a systematic review and meta-analysis of remote 
monitoring’s (telemedicine) on outcomes for patients with chronic heart failure. The results 
showed a positive relationship between telemedicine and improved patient outcomes. 
Specifically, Clark’s study showed a 20% lower risk of all-cause mortality with remote telehealth 
monitoring compared with those receiving usual care. Once again, this shows another study that 
supports this project’s hypothesis which is that telemedicine cardiovascular interventions 
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improve patient quality health measures. A statistical analysis technique in this paper worth 
noting is the use of risk ratios (RR’s), which are a common, effective way of evaluating this type 
of quantifiable data and the same ratio that will later be used to present some results of this 
research.  
Polisena et. al. (19) conducts a systematic review and meta-analysis on home telehealth for 
chronic obstructive pulmonary disease. This publication has a very similar study criteria design, 
extraction and analysis to that which is used in our research. This study was an example of a 
meta-analysis which used the I² statistic to quantify the percentage of variation across studies 
that is due to heterogeneity rather than chance. Polisena et. al. also included a table with all study 
intervention descriptions along with baseline patient characteristics that successfully gave insight 
into the specifics of the trials included in analysis. A similar model is used in our research to 
present this data.  
The work by Higgins and Johnson (12) discusses heterogeneity in meta-analysis, which is 
successfully used to demonstrate how the results of combined studies are different. 
Heterogeneity refers to the variability in results among different studies. This is therefore a very 
important aspect to consider in systematic reviews and meta-analysis because their whole 
objective is to combine multiple studies. This paper further discusses the main three appropriate 
statistics, H, R and I², used in calculating and comparing heterogeneity. This publication has a lot 
of statistical information relative to meta-analysis that is useful in conducting these types of 
reviews.  
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Hypothesis 
Telemedicine interventions are very broad and can include the diagnosis, communication 
of care, and treatment given remotely over technology. It is important to understand the effect of 
these interventions on patient’s health. The goal of this specific research project is to examine the 
success of telemedicine interventions in the prevention and treatment of cardiovascular disease 
management in patients. Success for this research will be measured by quality outcome measures 
including mortality and hospitalization measures. Ultimately the review and meta-analysis will 
be able to show, based on the available data, if these virtual health interventions for patients with 
cardiovascular conditions were able to lower death rates and/or decrease hospitalizations. A 
systematic review will be conducted to gather the cases on this topic that fulfill the study 
requirements and have the quantitative data to accurately conduct a meta-analysis.  
 Based on other related studies and the current move towards using more telemedicine in 
health care, the hypothesis of this research is that overall these interventions will reduce 
mortality and hospitalizations rates. Thus, meaning that telemedicine interventions used in the 
included cardiovascular condition management scenarios are beneficial, and have a positive 
relationship to health outcomes for patients.  
Methodology 
The methodologies chosen to test this idea are a systematic review and meta-analysis. 
This will allow for a more comprehensive and collaborative view, by statistically combining data 
from multiple controlled trials of these interventions. Different controlled studies that have been 
directed to test the same things have shown conflicting results. Some noted telemedicine 
interventions to be beneficial in these circumstances, while others have shown no statistical 
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difference in outcomes between intervention and control groups. Therefore, combining the 
relevant published controlled trials will be able to give a more conclusive overall answer to this 
question of if telemedicine interventions improve patient outcomes in cardiovascular condition 
management. A systematic review is a statistical technique used to review and summarize 
previous quantitative research. Like touched on earlier, this method can give valuable insight 
into the heterogeneity of a topic, in this case telemedicine interventions in cardiovascular 
disease, or heart disease patients. (11) Once again, the variables or indicators that will be used to 
measure health outcomes will be the primary outcome measures (all-cause mortality and all-
cause hospitalizations) and the secondary outcome measures (heart failure hospitalizations and 
cardiovascular hospitalizations).  
The next step in beginning a systematic review of the research is to define a criteria of 
studies to include in the meta-analysis. This research project will only include studies that meet 
all of the following requirements: 
1) The study must evaluate the effect of remote monitoring telemedicine interventions on 
cardiovascular conditions. This can include interventions in CVD patients, heart failure 
patients, or interventions used on patients at high risk for CVD. The sole objective of 
included studies should be to evaluate the effect of telemedicine interventions in patients 
with cardiovascular conditions, and not to evaluate other patients with additional 
conditions.   
2) The telemedicine interventions must include a transmission of physiologic parameters 
or patient health data to a health care professional. The telemedicine intervention must 
also be monitoring patients after their discharge from the hospital or healthcare setting, 
meaning it cannot be testing interventions only being used in the clinical setting.  
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3) there must be a comparison shown between a control group and an intervention group. 
It must be a two arm controlled trial and cannot include studies testing more than two 
intervention groups. 
4) quantitative data on mortality and all cause hospitalizations (as a number of total 
hospitalization events) must be provided. In addition to all cause hospitalization other 
hospitalization measures such as specifically heart failure and cardiovascular 
hospitalizations are preferred but not required for inclusion.   
Developing the search strategy is the next obstacle in completing a systematic review of the 
research. A boolean search strategy was used to explore major health databases (including 
PubMed, CINAHL, Cochrane Central Register of Controlled Trials, and Embase) and conduct a 
search for randomized controlled trials and clinical controlled trials published from January 1st, 
2000 to present day. Table 1 below lays out the Boolean search used for each individual 
database. The published article search brought a total 473 results from the four databases.  
Table 1: Search Strategy
 
After completing these searches within these chosen databases, a selection of the relevant 
studies that fulfilled all criteria to include in the review took place. This process began with a 
15 
 
review of all the abstracts obtained from the searches. All duplicate studies were removed, along 
with those that did not pertain to this research. The criteria listed above for inclusion was used 
when reading through the abstracts and any publication that obviously was not going to meet one 
or multiple of those criteria was dismissed. If the reviewer was unsure from the limited 
information given in an abstract and if there was any possibility of meeting the criteria, the 
article was still moved to review further. Due to these guidelines, after reviewing and reading 
through the abstracts 278 duplicate search results between databases were removed. An 
additional 118 studies were dismissed due to not meeting the specified inclusion criteria. Once 
completed, this then led to a comprehensive list of 77 potentially eligible abstracts, which were 
moved to review in full. Once reviewed in full, any study that included all the criteria set for this 
research was then used. Studies were excluded due to not meeting requirements because of 
inappropriate study design or wrong type of intervention/comparators. In addition, a common 
reason trials did not meet the criteria was because they did not include quantitative data on all-
cause mortality and hospitalization, the two required primary outcome measures. This led to the 
arrival of a final list of studies to include in the review and analysis. Figure 1 demonstrates the 
study selection process used for the systematic review.  
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Figure 1: Study Selection 
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Once a final list of studies had been decided upon, the next step was extracting the data from 
the studies. Basic patient and study characteristics along with an intervention and comparator 
description for each study are summarized in Table 2 below. Table 3 displays the quantitative 
data on outcome measures (mortality and hospitalizations) collected for each of the 13 studies.  
Table 2: Patient and Study Characteristics 
Study Country 
Study 
design 
Length of 
followup 
Comparison 
arms (patient 
characteristics) Intervention and comparator 
Boriani G. 2017 (1) 
International 
(9 countries) RCT 24 months 
Usual care - (n = 
428, M/F = 
312/116, mean 
age = 67±10)   
Telemedicine 
Intervention - 
(n = 437, M/F = 
342/95, mean 
age = 66±11)                
Patients in the Remote arm received a 
Carelink monitor for scheduled remote 
device checks and automatic alerts for 
lung fluid accumulation and atrial 
tachyarrhythmia. Those in the 
telemedicine intervention group 
received remote monitoring through 
the implanted biventricular 
defibrallator.                                                                                
Patients in the control group  received 
usual care from their physicians                          
Comín-Colet et al. 
2016 (6) unclear  RCT 12 months  
Usual care - (n = 
97, M/F = 
59/38, mean 
age = 75±11)   
Telemedicine 
Intervention - 
(n = 81, M/F = 
46/35, mean 
age = 74±11)                
In the Telemedicine group, these 
encounters were virtual contacts by 
videoconference, audio-conference or 
telephone between the health care 
professional and the patient and 
caregiver (at home). All patients in the 
Intervention group performed daily 
automated telemonitoring of 
biometrics and symptoms using the 
home THC platform. Telemedicine HF 
nurses reviewed alarms and alerts 
from the system everyday                                                                                  
Patients in the control group  received 
usual care from their physicians   
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Pedone et al. 2015 
(18) 
United 
States RCT 6 months 
usual care - (n = 
43, M/F = 
13/30, mean 
age = 79.7±7.8)                         
Telemedicine 
intervention - 
(n = 47, M/F = 
22/25, mean 
age = 79.9±6.8) 
The intervention included a 
telemonitoring system and office-
hours telephonic support provided by 
a geriatrician who had access to the 
telemonitoring system. The 
telemonitoring system consists of 
commercial measurement devices 
equipped with a transmitter and a 
commercial android-based 
smartphone that receives from the 
transmitter.                                                                                        
Patients in the control group received 
usual standard care from their 
physicians.  
De Simone et al. 
2015 (7) Italy RCT 12 months  
Usual care - (n = 
488, M/F = 
380/108, mean 
age = 66±13)   
Telemedicine 
Intervention - 
(n = 499, M/F = 
379/120, mean 
age = 66±12)                
The study population underwent 
ICD/CRT-D implantation and the 
intervention group was remotely 
monitored through this device. All 
systems allowed full interrogation and 
transmission of ICD data through a 
standard telephone connection or the 
mobile network, at scheduled intervals 
or in the case of programmable alert 
conditions, without patient 
intervention.                                                         
Patients in the control group received 
usual standard care from their 
physicians in the form of conventional 
in-clinic visits.  
Villani et al. 2014 
(22) unclear  RCT 12 months  
usual care - (n = 
40, M/F = 
29/18, mean 
age = 73±5)                         
Telemedicine 
intervention - 
(n = 40, M/F = 
30/4, mean age 
= 71±4) 
In the telemedicine intervention group 
patients were asked to transmit the 
requested information at a scheduled 
time. 
A pre-set acoustic alarm reminded 
them of the timing. The 
PDA was also structured for remote 
transmission of ECG 
and blood pressure data collected with 
a commercial 
device.                                                                                                 
Patients in the control group received 
usual standard care from their 
physicians.  
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Hindricks et al. 
2014 (12) 
International 
(3 countries) RCT 12 months  
usual care - (n = 
331, M/F = 
262/49, mean 
age = 65±8)                         
Telemedicine 
intervention - 
(n = 333, M/F = 
274/59, mean 
age = 65±3) 
Patients received a commercially 
available Lumax dual-chamber ICD or 
CRT-D (Biotronik SE & Co. KG, Berlin, 
Germany), equipped with a Biotronik 
Home Monitoring function. 
Transmitted data were reviewed by a 
central monitoring unit composed of 
trained study nurses and supporting 
physicians, located at the Heart Center 
Leipzig (Germany                                                                                         
Patients in the control group received 
usual standard care from their 
physicians.  
Boyne et al. 2012 
(2) Netherlands RCT 12 months  
usual care - (n = 
185, M/F = 
116/74, mean 
age = 72±11)                         
Telemedicine 
intervention - 
(n = 197, M/F = 
115/82, mean 
age = 71±12) 
The patients in the intervention arm 
received a device, with a liquid crystal 
display and four keys, connected to a 
landline phone. Automatic transfer of 
vital signs to HC professional. Positive 
answers for symptoms triggered 
immediate responses by the heart 
failure nurse. The process was led by a 
heart failure nurse and a nurse 
assistant. The nurse assistant took care 
of educational and general high risks, 
such as persistent lack of adherence or 
symptoms of depression.                                                                                        
Patients in the control group received 
usual standard care from their 
physicians 
Chaudhry et al. 
2010 (3) unclear  RCT 6 months 
usual care - (n = 
827, M/F = 
491/336, 
median age = 
61)                         
Telemedicine 
intervention - 
(n = 826, M/F = 
467/359, 
median age = 
61) 
Telemonitoring was performed with 
the use of a commercial system, Tel-
Assurance (Pharos Innovations). At 
baseline, site coordinators (clinical 
professionals) collected the medical 
history and physical-examination data 
by means of direct interview, 
examination, and medical-record 
review.                                                                                                 
Patients in the control group received 
usual standard care from their 
physicians.   
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Scherr et al. 2009 
(21) unclear  RCT 6 months 
usual care - (n = 
54, M/F = 
39/15, median 
age = 67)                         
Telemedicine 
intervention - 
(n = 54, M/F = 
40/14, median 
age = 65) 
The MOBITEL telemedicine platform 
was developed as a three-tier, client-
server architecture (data, logic, and 
representation layers) using state-of-
the-art Internet technology. ele group 
patients were asked to measure vital 
parameters (blood pressure, heart 
rate, body weight) on a daily basis at 
the same time, preferably in the 
morning after emptying the bladder 
and before dressing and taking 
medication. Data was transferred to 
monitoring center where study 
physicians reviewed results.                                   
Patients in the control group received 
usual standard care from their 
physicians.  
Kashem et al. 
2008 (13) 
United 
States RCT 12 months  
usual care - (n = 
24, M/F = 18/6, 
mean age = 
54±11)                         
Telemedicine 
intervention - 
(n = 24, M/F = 
17/7, mean age 
= 53±10) 
The telemedicine system (InSight 
Telehealth Systems, LLC, Valley Forge, 
Pennsylvania) is an interactive health 
care communication system 
comprising a secure Internet server 
and a database with Web-based access 
by patients and providers. Patients 
enter blood pressure and heart rate 
obtained with a digital 
sphygmomanometer, weight obtained 
with a scale, and answer 5 questions 
regarding changes in symptoms. Data 
was sent electronically to provider to 
be monitored. An advanced HF nurse 
was hired for this clinical study who 
was dedicated to reviewing HF patient 
information                                                                       
Patients in the control group received 
usual standard care from their 
physicians. 
Koehler et al. 
2011 (14) 
United 
States RCT 24 months 
usual care - (n = 
356, M/F = 
292/64, mean 
age = 
66.9±10.5)                         
Telemedicine 
intervention - 
(n = 354, M/F = 
285/69, mean 
age = 
66.9±10.8) 
For the telemedecine intervention 
group the following devices were part 
of the integrated sensor network: a 3-
lead ECG, a blood pressure device, and 
a weighing scale with 50-g precision. 
The patient performed a daily self-
assessment with these devices, and 
the data were transferred to the 
responsible telemedical center.                                                   
Patients in the control group  received 
usual care from their physicians  
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Sardu et al. 2016 
(20) Italy RCT  12 months  
usual care - (n = 
94, M/F = 
75/19, mean 
age = 72.6±5.7)                         
Telemedicine 
intervention - 
(n = 89, M/F = 
64/35, mean 
age = 71.8±8.5) 
In the telemedicine intervention group 
internal cardioverter defibrillator 
device (ICD) recipients were 
monitored. TM has been used to track 
info on the clinical status of heart 
failure patients treated by ICD and/or 
cardiac resynchronisation therapy 
defibrillator. This small portable 
patient device receives the data and 
relays them automatically over mobile 
phone links to the Home Monitoring 
Service Center where every patient in 
the TM group was under continuous, 
automatic remote monitoring during 
the entire study.                                                                                 
Patients in the control group  received 
usual care from their physicians          
Landolina et al. 
2012 (15) Italy RCT 16 months 
usual care - (n = 
101, M/F = 
76/25, median 
age = 69)                         
Telemedicine 
intervention - 
(n = 99, M/F = 
81/18, median 
age = 66) 
In the remote arm, all alerts regarding 
clinical management (intrathoracic 
impedance for fluid accumulation 
monitoring, atrial arrhythmias, ICD 
shocks delivered) were turned on for 
wireless notification through CareLink. 
Clinics checked the CareLink Web site 
at least once daily for transmissions                                                                                  
Patients in the control group  received 
usual care from their physicians   
 
Table 3: Extracted Patient Outcome Data 
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Data Analysis 
 All cause hospitalizations were analyzed using an incidence rate difference (IRD) 
calculation between the telemedicine intervention and usual care. Individual IRD’s were reported 
for each study. The next step performed was a meta-analysis using a random effects model which 
was the correct choice because it assumes that studies are measuring different, but still related, 
intervention effects which was the case in this research. This analysis led to a reported pooled 
IRD of -0.005. Another notable statistics related to this analysis were a p value of 0.1081 and an 
I² statistic of 78%. Table 4 displays the results of the meta-analysis for incidence rate difference 
of all cause hospitalization events between telemedicine intervention and usual care. 
Table 4: IRD of All Cause Hospitalizations 
 
All-cause mortality was also examined for each of the 13 included trials. Relative Risk 
(RR) Ratios were used to evaluate and compare these death rates between telemedicine 
intervention patients and usual care patients.  Once again, individual study RR’s were calculated 
which resulting in a pooled RR of 0.860. The p value was 0.134 and the I² statistic was 19.2%. 
These calculations are presented in Table 5. Furthermore, Figure 2 shows a forest tree 
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representation of the relative risk of mortality between the telemedicine intervention groups and 
usual care groups. 
Table 5: RR ratios of Mortality
 
Figure 2: RR of Mortality Meta-Analysis Forest Plot
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In addition to the primary outcome measures, which were all cause hospitalizations and 
all-cause mortality, the secondary outcome measures (heart failure hospitalizations and 
cardiovascular hospitalizations) were also statistically analyzed for the studies that reported these 
findings. Six of the thirteen studies included the number of heart failure hospitalizations for both 
the control and intervention group. Four of the studies stated the number of cardiovascular 
hospitalizations in the intervention and usual care populations. Once more RR ratios were used 
to compare this data for each situation. The pooled RR of heart failure hospitalizations between 
the telemedicine intervention and usual care was 0.790 and similarly the RR of cardiovascular 
hospitalizations was 0.811. The results of the analysis for heart failure hospitalizations and 
cardiovascular hospitalizations are shown in Table 6 and Table 7 respectively. The accompanied 
meta-analysis forest plots with corresponding data are shown in Figure 3 and 4.   
Table 6: RR of Heart Failure Hospitalizations 
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Figure 3: RR of Heart Failure Hospitalizations Meta-Analysis Forest Plot 
 
 
Table 7: RR of Cardiovascular Hospitalizations 
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Figure 4: RR of Cardiovascular Hospitalizations Meta-Analysis Forest Plot 
 
 
Results/Discussion 
The results from the IRD meta-analysis of all cause hospitalizations provides a somewhat 
unclear conclusion. Assuming a random effects model, it can be stated with 95% confidence that 
the incidence rate difference of all cause hospitalizations between the intervention patients and 
usual care patients is between -0.0111 and 0.0011. This signifies a relatively small difference 
between these incidences of all cause hospitalizations between groups. However, the p value of 
0.1081 indicates these findings are not significant. Additionally, the I² statistic is very high at 
78%, meaning there was notably significant heterogeneity between studies. These two facts 
question the integrity and derived conclusion from this analysis.  
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Based on a random effects model, the pooled death rates suggest a lower risk of mortality 
with the telemedicine intervention compared with usual care. (RR = 0.86, 95% CI: 0.705 – 
1.048) A RR under 1 suggests a lower risk of mortality with the telemedicine intervention, while 
as a RR over 1 suggests a lower risk of mortality for usual care treatment. Therefore, the pooled 
RR in this scenario conveys that the telemedicine intervention lowers the risk of all-cause 
mortality by about 14%. 10 of the 13 studies report lower RR ratios of mortality with the 
telemedicine intervention. However, the meta-analysis once again delivered a non-statistically 
significant outcome. (p value = 0.134) Statistical heterogeneity was tested with the I² statistic, 
which was 19.67% indicating no significant variability between studies.  
The pooled relative risk rate of heart failure hospitalization and cardiovascular 
hospitalization between telemedicine interventions and usual care were 0.790 and 0.811 
respectively. This suggests the risk of hospitalization in each situation was lower with the 
telemedicine intervention. The P value in the analysis of heart failure hospitalizations was 0.08, 
and for cardiovascular hospitalizations was 0.208. Yet gain this leads to results that are not 
statistically significant.   
The trends in relative risk show a lower risk of mortality and hospitalization with 
telemedicine in each analysis examining CV patients. There is importance in this reoccurring 
trend which implies that telemedicine does have a positive impact on health outcomes of patients 
with cardiovascular conditions. However, none of the evidence from the data collected is strong 
enough to signify statistical significance. This leads to a somewhat inconclusive conclusion.  
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Implications/Further Research 
 Further research should be conducted in this area to gain a more conclusive result. The 
limited number of studies included, which was 13, could have had an effect on none of the 
findings being statistically significant. A larger population and greater number of studies 
included in the meta-analysis could better the chance of finding statistically significant 
outcomes. The specificity of the inclusion criteria used in the study design of this research led to 
only a small portion of trials reviewed meeting the required criteria. In the future another 
systematic review and meta-analysis could be conducted with less stringent criteria that would 
allow for a greater number of studies to be included in the analysis.  
 In addition something to consider in future related research would be the specific type of 
intervention/device used in the telemedicine group. A subgroup analysis could be used to show if 
there is any difference in health outcomes due to what type of monitoring device is being 
employed in the intervention group. Also the health status of the patients in each trial could also 
have an effect on the results of the health outcomes. For example, if one patient population in the 
studies is sicker than the population in one of the other trials, that study could report higher 
levels of mortality than the other. This could influence the pooled calculations and have an effect 
on conclusions.  
 As explained before, telemedicine is being used around the world to allow for consistent 
monitoring of patients’ health. This is a valuable technology and more research should be 
conducted to better explain the direct benefits of engaging in this type of technology. The results 
of this study pointed toward improved patient outcomes, however the findings were not as 
conclusive as anticipated. Further research should be used to compile more results of randomized 
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controlled trials in relation to the use of telemedicine interventions in patients with CV 
conditions to draw stronger conclusions about health outcomes.  
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